We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$26.1M
2
RTN
Raytheon Company
RTN
+$22.2M
3
ABT icon
Abbott
ABT
+$20.8M
4
ELLI
Ellie Mae Inc
ELLI
+$19.9M
5
BURL icon
Burlington
BURL
+$19.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEOG icon
176
Neogen
NEOG
$2.05B
$2.3M 0.04%
109,664
+1,069
+1% +$22.9K
KO icon
177
Coca-Cola
KO
$354B
$2.29M 0.04%
54,174
+559
+1% +$24.5K
VTI icon
178
Vanguard Total Stock Market ETF
VTI
$654B
$2.27M 0.04%
20,399
+641
+3% +$71.1K
NLY.PRD
179
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
$2.24M 0.04%
88,565
-1,350
-2% -$34.7K
BHP icon
180
BHP
BHP
$213B
$2.22M 0.04%
71,819
+1,413
+2% +$38.8K
ASML icon
181
ASML
ASML
$675B
$2.19M 0.04%
19,946
-1,236
-6% -$131K
BMRN icon
182
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.18M 0.04%
23,567
– –
SSW.PRD
183
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
$2.16M 0.04%
86,635
-2,000
-2% -$51.3K
GRFS
184
Grifois
GRFS
$5.16B
$2.15M 0.04%
134,755
-10,250
-7% -$169K
SDY icon
185
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$2.15M 0.04%
+25,486
New +$2.17M
VNQ icon
186
Vanguard Real Estate ETF
VNQ
$39.9B
$2.09M 0.04%
24,128
-1,881
-7% -$168K
INXN
187
DELISTED
Interxion Holding N.V.
INXN
$2.08M 0.04%
57,431
-752
-1% -$28.1K
RGA icon
188
Reinsurance Group of America
RGA
$15.7B
$2.07M 0.04%
19,200
-50
-0.3% -$5.1K
MJN
189
DELISTED
Mead Johnson Nutrition Company
MJN
$2.05M 0.04%
25,903
-423
-2% -$36.1K
WFC icon
190
Wells Fargo
WFC
$261B
$2.04M 0.04%
46,102
-23,459
-34% -$1.12M
SPSC icon
191
SPS Commerce
SPSC
$2.25B
$2.03M 0.04%
55,394
+11,004
+25% +$362K
CHSCO
192
CHS Inc Class B Preferred Stock
CHSCO
$549M
$2M 0.04%
67,600
-5,400
-7% -$163K
AHT.PRD
193
Ashford Hospitality Trust Series D
AHT.PRD
$6.02M
$2M 0.04%
78,555
-3,550
-4% -$90.7K
ACIA
194
DELISTED
Acacia Communications Inc
ACIA
$1.99M 0.04%
19,285
+11,985
+164% +$1.04M
SRCLP
195
DELISTED
Stericycle, Inc
SRCLP
$1.99M 0.04%
30,020
+490
+2% +$36.3K
ADP icon
196
Automatic Data Processing
ADP
$100B
$1.98M 0.04%
22,500
+489
+2% +$44.3K
CERN
197
DELISTED
Cerner Corp
CERN
$1.98M 0.04%
32,057
-800
-2% -$50.5K
MDT icon
198
Medtronic
MDT
$107B
$1.94M 0.04%
22,420
-7
-0% -$610
MDLZ icon
199
Mondelez International
MDLZ
$77.7B
$1.92M 0.04%
43,650
+269
+0.6% +$11.8K
FULLL
200
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
$1.91M 0.04%
75,620
+1,320
+2% +$33.6K
6 7
8
9 10

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.